XML 80 R67.htm IDEA: XBRL DOCUMENT v3.22.1
Accounts and Notes Receivable (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Accounts Receivable - trade [1] $ 5,603 $ 5,231 $ 3,441  
Notes receivable - trade [1],[2] 426 533 120  
Other [3] 1,246 1,028 1,250  
Accounts and notes receivable - net 7,275 6,792 4,811  
Accounts Receivable, Allowance for Credit Loss, Current 232 203 210 $ 208
Due from Affiliates 124 115 104  
Factoring Agreement [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Trade Receivables Sold 17 11    
Trade receivables sold the remain outstanding with an element of recourse $ 130 $ 128 $ 166  
[1] Accounts receivable – trade and notes receivable - trade are net of allowances of $232 million, $210 million, and $203 million at March 31, 2022, December 31, 2021, and March 31, 2021, respectively. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method.
[2] Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of March 31, 2022, December 31, 2021, and March 31, 2021 there were no significant impairments related to current loan agreements.
[3] Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $124 million, $104 million, and $115 million as of March 31, 2022, December 31, 2021, and March 31, 2021, respectively.